Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (6)
- Biology and Environment (107)
- Biology and Soft Matter (1)
- Clean Energy (92)
- Climate and Environmental Systems (5)
- Computational Engineering (2)
- Computer Science (8)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (8)
- Fusion Energy (2)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (112)
- Materials Characterization (1)
- Materials for Computing (16)
- Materials Under Extremes (1)
- Mathematics (1)
- National Security (25)
- Neutron Science (35)
- Nuclear Science and Technology (4)
- Quantum information Science (2)
- Sensors and Controls (1)
- Supercomputing (71)
- Transportation Systems (1)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.